France announces additional savings of €1 billion on medicines for 2019Thursday’s Les Echos (brief p4) and Le Figaro (brief p21) reported that France plans additional savings of €1 billion on pharmaceuticals in the 2019 healthcare budget, which will be debated this autumn.
Novo Nordisk reorganises R&DLes Echos (brief p14) reported briefly on Thursday Novo Nordisk has decided to cut 400 jobs in R&D in Denmark and China, in order to streamline its research organisation.
BioVenture invests in HoramaOn Tuesday, Les Echos (p25) reported that investment fund BioVenture has entered the capital of French biotech Horama, which will allow the company to lead the clinical development of its primary candidate, Hora-PDE6B, a gene therapy targeting patients with hereditary eye diseases.
Biotech MedinCell launches IPOOn Wednesday, Les Echos (p27) noted that French biotech company MedinCell has launched an IPO, aiming to raise around €40 million.
Nicolas Giraud appointed vice-president Europe at Mayoly SpindlerThursday’s Les Echos (brief p3, Entreprises supplement) announced the appointment of Nicolas Giraud as vice-president Pharma Europe at Mayoly Spindler.
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.